• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Free or Unrestricted Flow (2945)
Patient Problem Pain (1994)
Event Date 10/28/2016
Event Type  malfunction  
Manufacturer Narrative
Medwatch sent to the fda on 12/07/2016.The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Device labeling addresses the reported events as follows: warnings and precautions: the physiological response of the patient to the presence of the orbera system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Complications - possible complications of the use of the orbera system include: - gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.- abdominal or back pain, either steady or cyclic.
 
Event Description
Reported as: a patient had the orbera intragastric balloon placed, and after a period, patient complained about "discomfort and abdominal pain.Doctor requested x-ray exam that confirmed air inside the balloon." the device was removed and replaced.
 
Manufacturer Narrative
Supplement #1: medwatch sent to fda on 01/25/2017.The device was returned to apollo.A visual examination was performed, and noted the returned device to be discolored, and the shell was blue in appearance.White particles were also noted on the outer surface of the shell, valve patch and valve channel.An opening/hole was noted on the radius of the device.A valve test was performed and the flow of di water was continues and unobstructed.An air leak test was performed and leakage was noted from a single opening on the radius of the shell.The openings were noted to be striated, consistent with damage from a surgical tool.Under microscopic analysis, black particles were observed in the valve channel/hole.
 
Manufacturer Narrative
Supplement #2 - medwatch sent to the fda on 26-jul-2017.Device evaluation summary: additional testing was performed on the device.The valve was noted to be leaking.The slit valve was removed from the device using a razor blade for testing.Pressure testing of the slit valve was performed, the outside to inside pressure was noted to be 0.19 psi.The inside to outside pressure was noted to be 0.29 psi.The valve was cross-sectioned along the sealing mechanism, and examined microscopically with a magnification between 20x-60x.The surface of sealing mechanism showed typical axial lines parallel to the valve access due to the blade cutting direction during valve manufacturing.The inner edge of the cut appeared to be more defined than the opposite edge, likely a consequence of the valve slitting process.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia,
CS  
Manufacturer Contact
laura leboeuf
1120 s. captial of texas hwy
bldg 1, ste. 300
austin, TX 78746
5122795141
MDR Report Key6151104
MDR Text Key61665014
Report Number3006722112-2016-00379
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date05/26/2017
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot Number2744842
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2016
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/01/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/26/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PANTOPRAZOL
Patient Outcome(s) Required Intervention;
Patient Age43 YR
Patient Weight78
-
-